- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01912703
The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years
July 30, 2013 updated by: Hillel Yaffe Medical Center
It is well-known that preterm delivery can be accompanied by complications.
One of these complications is Intraventricular Hemorrhage (IVH).
There are four degrees of IVH, according to severity.
It is known that IVH Grades 3-4 can cause severe neurodevelopmental outcomes, including cerebral palsy (CP), hemiplegia, lower motor and cognitive skills and social difficulties.
It is not known whether IVH Grades I-II have any of these effects and the aim of this study is to determine whether they do have any neurodevelopmental outcomes.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
700
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Roei Abramovitch, MD
- Phone Number: 972-50-3205548
- Email: roeiabra@gmail.com
Study Locations
-
-
-
Hadera, Israel, 38100
- Hillel Yaffe Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 7 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Preterm infants born in 2007-2011 at the Hillel Yaffe Medical Center
Description
Inclusion Criteria:
- All preterm infants born at 35 weeks or less
- Underwent at least 1 brain ultrasound
- Diagnosed with IVH Grades 1-2
- Had no other severe illness in NICU
- Had neurodevelopmental follow-up
Exclusion Criteria:
- All others
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Preterm infants with IVH Grades I-II
Preterm infants (post-menstrual age 24-35 weeks) who were diagnosed with IVH Grades 1-2 in the neonatal intensive care unit (NICU).
|
Subjects with incomplete data will be asked to complete a telephone interview
|
Control Group
Preterm infants (post-menstrual age 24-35 weeks) who had no imaging evidence of IVH in the neonatal intensive care unit (NICU).
|
Subjects with incomplete data will be asked to complete a telephone interview
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
General Neurodevelopmental Assessment
Time Frame: Seven years
|
Retrospective study of preterm infants born in the years 2007-2011 and suffered IVH Grades 1-2 who have undergone a general neurodevelopmental assessment in the Institute for Child Development in Hillel Yaffe Medical Center at ages 1-7.
This assessment will indicate whether IVH Grades 1-2 has any neurodevelopmental effect on these children.
|
Seven years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2013
Primary Completion (Anticipated)
December 1, 2014
Study Completion (Anticipated)
December 1, 2014
Study Registration Dates
First Submitted
July 29, 2013
First Submitted That Met QC Criteria
July 30, 2013
First Posted (Estimate)
July 31, 2013
Study Record Updates
Last Update Posted (Estimate)
July 31, 2013
Last Update Submitted That Met QC Criteria
July 30, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- HYMC-297-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Infants
-
University of ManitobaCompleted
-
Hadassah Medical OrganizationWithdrawnPreterm Infants With White Matter Damage | Preterm Infants Developing Normally
-
Selcuk UniversityCompletedPremature InfantsTurkey
-
Firat UniversityCompleted
-
Materna LaboratoriesCompleted
-
Radboud University Medical CenterUniversity Medical Center Groningen; UMC Utrecht; Erasmus Medical Center; Amsterdam... and other collaboratorsCompletedPremature Birth | Extremely Premature Infants
-
AbbottAssign Data Management and Biostatistics GmbHCompleted
-
Baylor College of MedicineMead Johnson Nutrition; The Children's Nutrition Research CenterActive, not recruiting
-
Baylor College of MedicineSuspendedPremature InfantsUnited States
Clinical Trials on Telephone interview
-
Dongzhimen Hospital, BeijingUnknown
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Centre Hospitalier le MansUnknownOsteoporosis | Osteoporotic FracturesFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingInformation Remembered by Parents Following the Ingestion of Foreign Body by Their ChildFrance
-
University of PennsylvaniaEnrolling by invitationFrontotemporal Degeneration | Frontotemporal Dementia | Frontotemporal Dementia, Behavioral Variant | FTDUnited States
-
University Hospital, BordeauxActive, not recruitingStroke | Stroke SequelaeFrance
-
Fundación Pública Andaluza para la Investigación...UnknownDementia | Mild Cognitive ImpairmentSpain
-
University Hospital, AngersCompleted
-
Rennes University HospitalCompletedArteriovenous MalformationsFrance
-
CHU de ReimsCompleted